Author response for "A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL"
Toby A. Eyre, Catherine Hildyard, Angela Hamblin, Ayesha S. Ali, Aimee Houlton, Louise Hopkins, Daniel Royston, Kim M. Linton, Andrew Pettitt, Simon Rule, Kate Cwynarski, Sally F. Barrington, Victoria Warbey, David Wrench, Sharon Barrans, Caroline S. Hirst, Anesh Panchal, Martine P. Roudier, Elizabeth A. Harrington, Andrew Davies, Graham P. Collins crossref(2019)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)